Cepheid Files Countersuit against Abaxis in Reagent Patent Dispute

The dispute stems from a licensing agreement in 2005 covering reagent patents held by Abaxis. Cepheid filed a countersuit yesterday, claiming it has not breached the license and asking the court to declare Abaxis' patents invalid.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.